
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combinatorial, additive and dose-dependent drug–microbiome associations
Sofia K. Forslund, Rima Chakaroun, Maria Zimmermann‐Kogadeeva, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 500-505
Closed Access | Times Cited: 166
Sofia K. Forslund, Rima Chakaroun, Maria Zimmermann‐Kogadeeva, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 500-505
Closed Access | Times Cited: 166
Showing 1-25 of 166 citing articles:
Microbiome and metabolome features of the cardiometabolic disease spectrum
Sébastien Fromentin, Sofia K. Forslund, Kanta Chechi, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 303-314
Open Access | Times Cited: 174
Sébastien Fromentin, Sofia K. Forslund, Kanta Chechi, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 303-314
Open Access | Times Cited: 174
An online atlas of human plasma metabolite signatures of gut microbiome composition
Koen F. Dekkers, Sergi Sayols-Baixeras, Gabriel Baldanzi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 134
Koen F. Dekkers, Sergi Sayols-Baixeras, Gabriel Baldanzi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 134
Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease
Yeela Talmor‐Barkan, Noam Bar, Aviv A. Shaul, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 295-302
Closed Access | Times Cited: 127
Yeela Talmor‐Barkan, Noam Bar, Aviv A. Shaul, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 295-302
Closed Access | Times Cited: 127
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
Raaj S. Mehta, Jared R. Mayers, Yancong Zhang, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 700-709
Open Access | Times Cited: 76
Raaj S. Mehta, Jared R. Mayers, Yancong Zhang, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 700-709
Open Access | Times Cited: 76
Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models
Rosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 3, pp. 399-408
Open Access | Times Cited: 61
Rosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 3, pp. 399-408
Open Access | Times Cited: 61
The gut microbiota in multiple sclerosis varies with disease activity
Florence Thirion, Finn Sellebjerg, Yong Fan, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Florence Thirion, Finn Sellebjerg, Yong Fan, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Enterosignatures define common bacterial guilds in the human gut microbiome
Clémence Frioux, Rebecca Ansorge, Ezgi Özkurt, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 7, pp. 1111-1125.e6
Open Access | Times Cited: 50
Clémence Frioux, Rebecca Ansorge, Ezgi Özkurt, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 7, pp. 1111-1125.e6
Open Access | Times Cited: 50
A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage
Ting Li, Ning Ding, Hanqing Guo, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 191-208.e9
Open Access | Times Cited: 45
Ting Li, Ning Ding, Hanqing Guo, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 191-208.e9
Open Access | Times Cited: 45
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
Jianqing She, Gulinigaer Tuerhongjiang, Manyun Guo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 408-421.e5
Open Access | Times Cited: 21
Jianqing She, Gulinigaer Tuerhongjiang, Manyun Guo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 2, pp. 408-421.e5
Open Access | Times Cited: 21
Multi-omic approaches for host-microbiome data integration
Ashwin Chetty, Ran Blekhman
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20
Ashwin Chetty, Ran Blekhman
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 20
Western diets and chronic diseases
Timon E. Adolph, Herbert Tilg
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2133-2147
Closed Access | Times Cited: 18
Timon E. Adolph, Herbert Tilg
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2133-2147
Closed Access | Times Cited: 18
Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes
Zhendong Mei, Fenglei Wang, Amrisha Bhosle, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2265-2276
Closed Access | Times Cited: 17
Zhendong Mei, Fenglei Wang, Amrisha Bhosle, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2265-2276
Closed Access | Times Cited: 17
Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk
Tiange Wang, Zhun Shi, Huahui Ren, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1722-1731
Closed Access | Times Cited: 16
Tiange Wang, Zhun Shi, Huahui Ren, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1722-1731
Closed Access | Times Cited: 16
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Rima Chakaroun, Lisa Olsson, Fredrik Bäckhed
Nature Reviews Cardiology (2022) Vol. 20, Iss. 4, pp. 217-235
Closed Access | Times Cited: 67
Rima Chakaroun, Lisa Olsson, Fredrik Bäckhed
Nature Reviews Cardiology (2022) Vol. 20, Iss. 4, pp. 217-235
Closed Access | Times Cited: 67
Diet-gut microbiota interactions on cardiovascular disease
Xufei Zhang, Philippe Gérard
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1528-1540
Open Access | Times Cited: 59
Xufei Zhang, Philippe Gérard
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1528-1540
Open Access | Times Cited: 59
Human Gut Antibiotic Resistome and Progression of Diabetes
Menglei Shuai, Guoqing Zhang, Fangfang Zeng, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 53
Menglei Shuai, Guoqing Zhang, Fangfang Zeng, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 53
The Metabolic Role and Therapeutic Potential of the Microbiome
Louise E. Olofsson, Fredrik Bäckhed
Endocrine Reviews (2022) Vol. 43, Iss. 5, pp. 907-926
Open Access | Times Cited: 52
Louise E. Olofsson, Fredrik Bäckhed
Endocrine Reviews (2022) Vol. 43, Iss. 5, pp. 907-926
Open Access | Times Cited: 52
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Integrating and formatting biomedical data as pre-calculated knowledge graph embeddings in the Bioteque
Adrià Fernández‐Torras, Miquel Duran‐Frigola, Martino Bertoni, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Adrià Fernández‐Torras, Miquel Duran‐Frigola, Martino Bertoni, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential
Hubert Krukowski, Sophie Valkenburg, Avra-Melina Madella, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 87-101
Closed Access | Times Cited: 44
Hubert Krukowski, Sophie Valkenburg, Avra-Melina Madella, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 87-101
Closed Access | Times Cited: 44
Plasma metabolic fingerprints for large-scale screening and personalized risk stratification of metabolic syndrome
Yifan Chen, Wei Xu, Wei Zhang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 7, pp. 101109-101109
Open Access | Times Cited: 35
Yifan Chen, Wei Xu, Wei Zhang, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 7, pp. 101109-101109
Open Access | Times Cited: 35
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators
Pedrum Mohammadi‐Shemirani, Tushar Sood, Guillaume Paré
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 2, pp. 55-65
Open Access | Times Cited: 30
Pedrum Mohammadi‐Shemirani, Tushar Sood, Guillaume Paré
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 2, pp. 55-65
Open Access | Times Cited: 30
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Alexandra L. Degraeve, Vincent Haufroid, Axelle Loriot, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Alexandra L. Degraeve, Vincent Haufroid, Axelle Loriot, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Extension of the Segatella copri complex to 13 species with distinct large extrachromosomal elements and associations with host conditions
Aitor Blanco‐Míguez, Eric J. C. Gálvez, Edoardo Pasolli, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1804-1819.e9
Open Access | Times Cited: 28
Aitor Blanco‐Míguez, Eric J. C. Gálvez, Edoardo Pasolli, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1804-1819.e9
Open Access | Times Cited: 28
Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide
Petros Andrikopoulos, Judith Aron‐Wisnewsky, Rima Chakaroun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Petros Andrikopoulos, Judith Aron‐Wisnewsky, Rima Chakaroun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23